Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
J Immunol ; 184(8): 4107-14, 2010 Apr 15.
Article in English | MEDLINE | ID: mdl-20212092

ABSTRACT

Cross-presentation of soluble Ag on MHC class I molecules to naive CD8 T cells by liver sinusoidal endothelial cells (LSECs) leads to induction of T cell tolerance that requires interaction between coinhibitory B7-H1 on LSECs and programmed cell death-1 on CD8 T cells. In this study, we investigate whether cross-presentation of high as well as low Ag concentrations allowed for LSEC-induced tolerance. Ag concentration directly correlated with the cross-presentation capacity of murine LSECs and thus strength of TCR stimulation. Although LSEC cross-presentation at low-Ag concentrations resulted in tolerance, they induced differentiation into effector T cells (CTL) at high-Ag concentrations. CTL differentiation under these conditions was not caused by increased expression of costimulatory CD80/86 on cross-presenting LSECs but was determined by early IL-2 release from naive CD8 T cells. B7-H1 signals from LSECs and TCR avidity reciprocally controlled early T cell release of IL-2 and CTL differentiation. B7-H1 expression directly correlated with cross-presentation at low- but not high-Ag concentrations, indicating an imbalance between TCR and coinhibitory signals regulating T cell release of IL-2. Exogenous IL-2 overrode coinhibitory B7-H1-mediated signals by LSECs and induced full CTL differentiation. Our results imply that LSEC-mediated T cell tolerance can be broken in situations where T cells bearing high-avidity TCR encounter LSECs cross-presenting high numbers of cognate MHC class I peptide molecules, such as during viral infection of the liver. Furthermore, we attribute a novel costimulatory function to IL-2 acting in a T cell autonomous fashion to promote local induction of immunity in the liver even in the absence of CD80/86 costimulation.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , Endothelial Cells/cytology , Endothelial Cells/immunology , Immune Tolerance/immunology , Liver/cytology , Liver/immunology , Animals , Antigen Presentation/immunology , CD8-Positive T-Lymphocytes/metabolism , Cells, Cultured , Coculture Techniques , Cross-Priming/immunology , Cytotoxicity Tests, Immunologic , Endothelial Cells/metabolism , Lymphocyte Activation/immunology , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic , Ovalbumin/immunology , Ovalbumin/metabolism , Resting Phase, Cell Cycle/immunology
2.
Gastroenterology ; 138(1): 336-46, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19737567

ABSTRACT

BACKGROUND & AIMS: Dendritic cell activation through ligation of pattern recognition receptors leading to full functional maturation causes induction of CD8(+) T-cell immunity through increased delivery of costimulatory signals instead of tolerance. Here we investigate whether organ-resident antigen-presenting cells, such as liver sinusoidal endothelial cells (LSECs), also switch from tolerogenic to immunogenic CD8(+) T-cell activation upon such stimulation. METHODS: Murine LSECs were isolated by immunomagnetic separation and analyzed for functional maturation upon triggering pattern recognition receptors or viral infection employing gene expression analysis and T cell coculture assays. In vivo relevance of the findings was confirmed with bone-marrow chimeric animals. RESULTS: LSECs expressed numerous pattern recognition receptors that allowed for sentinel function, but ligand-induced activation of these receptors was not sufficient to overcome tolerance induction of CD8(+) T cells. Importantly, viral infection with murine cytomegalovirus caused functional maturation of antigen-presenting LSECs and was sufficient to promote antigen-specific differentiation into effector CD8(+) T cells in the absence of dendritic cells and independent of CD80/86. CONCLUSIONS: These results shed new light on the generation of organ-specific immunity and may contribute to overcoming tolerance in relevant situations, such as cancer.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/virology , Herpesviridae Infections/immunology , Immune Tolerance/immunology , Liver/virology , Muromegalovirus , Adoptive Transfer , Animals , Bone Marrow , CD8-Positive T-Lymphocytes/cytology , Cell Differentiation/immunology , Cells, Cultured , Chimera , Endothelial Cells/cytology , Endothelial Cells/virology , Ligands , Liver/cytology , Liver/immunology , Mice , Oligonucleotide Array Sequence Analysis , Organ Specificity , Receptors, Pattern Recognition/genetics , Receptors, Pattern Recognition/immunology , Receptors, Pattern Recognition/metabolism
3.
Hepatology ; 50(3): 909-19, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19610048

ABSTRACT

UNLABELLED: Cross-presentation is an important function of immune competent cells, such as dendritic cells (DCs), macrophages, and an organ-resident liver cell population, i.e., liver sinusoidal endothelial cells (LSECs). Here, we characterize in direct comparison to DCs the distinct dynamics and kinetics of cross-presentation employed by LSECs, which promote tolerance induction in CD8 T cells. We found that LSECs were as competent in cross-presenting circulating soluble antigen ex vivo as DCs at a per-cell basis. However, antigen uptake in vivo was 100-fold more pronounced in LSECs, indicating distinct mechanisms of cross-presentation. In contrast to mannose-receptor-mediated antigen uptake and routing into stable endosomes dedicated to cross-presentation in DCs, we observed distinct antigen-uptake and endosomal routing with high antigen turnover in LSECs that resulted in short-lived cross-presentation. Receptor-mediated endocytosis did not always lead to cross-presentation, because immune-complexed antigen taken up by the Fc-receptor was not cross-presented by LSECs, indicating that induction of CD8 T cell tolerance by LSECs is impaired in the presence of preexisting immunity. CONCLUSION: These results provide a mechanistic explanation how organ-resident LSECs accommodate continuous scavenger function with the capacity to cross-present circulating antigens using distinct kinetics and dynamics of antigen-uptake, routing and cross-presentation compared to DCs.


Subject(s)
Cross-Priming/immunology , Dendritic Cells/immunology , Endothelial Cells/immunology , Liver/immunology , Animals , Antigens/metabolism , CD8-Positive T-Lymphocytes/immunology , Endocytosis/physiology , Lectins, C-Type/metabolism , Liver/cytology , Mannose Receptor , Mannose-Binding Lectins/metabolism , Mice , Mice, Inbred C57BL , Ovalbumin/metabolism , Receptors, Cell Surface/metabolism
4.
BMC Musculoskelet Disord ; 11: 267, 2010 Nov 18.
Article in English | MEDLINE | ID: mdl-21087470

ABSTRACT

BACKGROUND: Although the numbers of total knee arthroplasty (TKA) are increasing, there is only a small number of studies investigating driving safety after TKA. The parameter 'Brake Response Time (BRT)' is one of the most important criteria for driving safety and was therefore chosen for investigation.The present study was conducted to test the hypotheses that patients with right- or left-sided TKA show a significant increase in BRT from pre-operative (pre-op, 1 day before surgery) to post-operative (post-op, 2 weeks post surgery), and a significant decrease in BRT from post-op to the follow-up investigation (FU, 8 weeks post surgery). Additionally, it was hypothesized that the BRT of patients after TKA is significantly higher than that of healthy controls. METHODS: 31 of 70 consecutive patients (mean age 65.7 +/- 10.2 years) receiving TKA were tested for their BRT pre-op, post-op and at FU. BRT was assessed using a custom-made driving simulator. We used normative BRT data from 31 healthy controls for comparison. RESULTS: There were no significant increases between pre-op and post-op BRT values for patients who had undergone left- or right-sided TKA. Even the proportion of patients above a BRT threshold of 700 ms was not significantly increased postop. Controls had a BRT which was significantly better than the BRT of patients with right- or left-sided TKA at all three time points. CONCLUSION: The present study showed a small and insignificant postoperative increase in the BRT of patients who had undergone right- or left-sided TKA. Therefore, we believe it is not justified to impair the patient's quality of social and occupational life post-surgery by imposing restrictions on driving motor vehicles beyond an interval of two weeks after surgery.


Subject(s)
Arthroplasty, Replacement, Knee , Automobile Driving , Knee Joint/physiology , Knee Joint/surgery , Osteoarthritis, Knee/surgery , Reaction Time/physiology , Aged , Case-Control Studies , Cohort Studies , Female , Humans , Male , Middle Aged , Osteoarthritis, Knee/physiopathology , Postoperative Period , Prospective Studies , Quality of Life , Recovery of Function/physiology , Safety , Time Factors
5.
World J Gastroenterol ; 12(6): 974-6, 2006 Feb 14.
Article in English | MEDLINE | ID: mdl-16521231

ABSTRACT

Infections are a major adverse effect during the treatment with anti-TNF-alpha. While exclusion of any bacterial infection and screening for tuberculosis are mandatory before initiating a therapy with anti-TNF-alpha-antibodies, there are no guidelines whether to screen for or how to deal with chronic viral infections such as hepatitis B. In this case report, we have described a patient with Crohn's disease who developed subfulminant hepatitis B after the fourth infusion of infliximab due to an unrecognized HBs-antigen carrier state. He recovered completely after lamivudine therapy was started, but this severe adverse event could have been prevented if screening for HBV and pre-emptive therapy with lamivudine would have been started prior to infliximab. We therefore strongly argue in favor of extended screening recommendations for infectious diseases including viral infections before considering a therapy with infliximab.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Crohn Disease/drug therapy , Hepatitis B virus/isolation & purification , Hepatitis B/diagnosis , Antibodies, Monoclonal/adverse effects , Humans , Infliximab , Male , Mass Screening , Middle Aged
6.
World J Gastroenterol ; 10(13): 1918-22, 2004 Jul 01.
Article in English | MEDLINE | ID: mdl-15222037

ABSTRACT

AIM: Cyclooxygenases (COX) are key enzymes for conversion of arachidonic acid to prostaglandins. Nitric oxide synthase (NOS) is the enzyme responsible for formation of nitric oxide. Both have constitutive and inducible isoforms. The inducible isoforms (iNOS and COX-2) are of great interest as regulators of tumor angiogenesis, tumorigenesis and inflammatory processes. This study was to clarify their role in pancreatic adenocarcinomas. METHODS: We investigated the immunohistochemical iNOS and COX-2 expression in 40 pancreatic ductal adenocarcinomas of different grade and stage. The results were compared with microvessel density and clinicopathological data. RESULTS: Twenty-one (52.5%) of the cases showed iNOS expression, 15 (37.5%) of the cases were positive for COX-2. The immunoreaction was heterogeneously distributed within the tumors. Staining intensity was different between the tumors. No correlation between iNOS and COX-2 expression was seen. There was no relationship with microvessel density. However, iNOS positive tumors developed more often distant metastases and the more malignant tumors showed a higher COX-2 expression. There was no correlation with other clinicopathological data. CONCLUSION: Approximately half of the cases expressed iNOS and COX-2. These two enzymes do not seem to be the key step in angiogenesis or carcinogenesis of pancreatic adenocarcinomas. Due to a low prevalence of COX-2 expression, chemoprevention of pancreatic carcinomas by COX-2 inhibitors can only achieve a limited success.


Subject(s)
Adenocarcinoma/blood supply , Adenocarcinoma/metabolism , Isoenzymes/metabolism , Nitric Oxide Synthase/metabolism , Pancreatic Neoplasms/blood supply , Pancreatic Neoplasms/metabolism , Prostaglandin-Endoperoxide Synthases/metabolism , Adenocarcinoma/pathology , Aged , Aged, 80 and over , Cyclooxygenase 2 , Female , Humans , Immunohistochemistry , Male , Membrane Proteins , Microcirculation , Middle Aged , Nitric Oxide Synthase Type II , Pancreas/blood supply , Pancreas/enzymology , Pancreas/pathology , Pancreatic Neoplasms/pathology
7.
J Biol Chem ; 281(42): 31517-27, 2006 Oct 20.
Article in English | MEDLINE | ID: mdl-16940297

ABSTRACT

Merozoites of the malaria parasite Plasmodium falciparum expose at their surface a large multiprotein complex, composed of proteolytically processed, noncovalently associated products of at least three genes, msp-1, msp-6, and msp-7. During invasion of erythrocytes, this complex is shed from the surface except for a small glycosylphosphatidylinositol-anchored portion originating from MSP-1. The proteolytic cleavage separating the C-terminal portion of MSP-1 is required for successful invasion. Little is known about the structure and function of the abundant and essential multipartite complex. Using heterologously produced MSP-1, MSP-6, and MSP-7 in precursor and with the exception of MSP-7 in processed form, we have studied in vitro the complex formation between the different proteins to identify the interaction partners within the complex. Both MSP-6(36) and MSP-7 bind only to MSP-1 subunits that are shed, but although MSP-6(36) contacts just subunit p38, MSP-7 interacts with p83, p30, and p38. The intact C-terminal region of MSP-6 is required for the association with p38 as well as for its multimerization into tetramers. Furthermore, our data suggest that only the processed form and not the precursor form of MSP-1 interacts with MSP-6(36). MSP-6- as well as MSP-7-specific rabbit antibodies inhibit parasite multiplication in vitro as shown previously for antibodies directed against MSP-1. Our findings raise interesting questions with regard to proteolysis-mediated mechanisms of maturation of the MSP-1-MSP-6-MSP-7 complex and to the mode by which antibodies directed against this complex interfere with parasite multiplication.


Subject(s)
Erythrocytes/parasitology , Membrane Proteins/chemistry , Merozoite Surface Protein 1/chemistry , Plasmodium falciparum/metabolism , Protozoan Proteins/chemistry , Animals , Cloning, Molecular , Cross-Linking Reagents/pharmacology , Erythrocytes/metabolism , Flow Cytometry , Humans , Models, Genetic , Protein Binding , Protein Conformation , p38 Mitogen-Activated Protein Kinases/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL